In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity
出版年份 2022 全文链接
标题
In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 151, Issue -, Pages 113124
出版商
Elsevier BV
发表日期
2022-05-17
DOI
10.1016/j.biopha.2022.113124
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin
- (2021) Thuy Van Lam van et al. ACS Medicinal Chemistry Letters
- Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2
- (2021) Hanjun Zhao et al. Nature Communications
- Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes
- (2021) Zelma Faisal et al. BIOMEDICINE & PHARMACOTHERAPY
- SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
- (2021) Michihito Sasaki et al. mBio
- In vitro interaction of potential antiviral TMPRSS2 inhibitors with human serum albumin and cytochrome P 450 isoenzymes
- (2021) Erzsébet Pászti-Gere et al. BIOMEDICINE & PHARMACOTHERAPY
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
- (2020) Ruochen Zang et al. Science Immunology
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
- (2020) Hanjun Zhao et al. Nature Communications
- Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
- (2020) Ya-Wen Cheng et al. Cell Reports
- Peptide and peptide-based inhibitors of SARS-CoV-2 entry
- (2020) Desiree Schütz et al. ADVANCED DRUG DELIVERY REVIEWS
- Interaction of Mycotoxin Alternariol with Serum Albumin
- (2019) Eszter Fliszár-Nyúl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics
- (2018) Zelma Faisal et al. Mycotoxin Research
- Interaction of Chrysin and Its Main Conjugated Metabolites Chrysin-7-Sulfate and Chrysin-7-Glucuronide with Serum Albumin
- (2018) Violetta Mohos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The biology and therapeutic targeting of the proprotein convertases
- (2012) Nabil G. Seidah et al. NATURE REVIEWS DRUG DISCOVERY
- Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics
- (2009) Gero L. Becker et al. JOURNAL OF MEDICINAL CHEMISTRY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started